Musculoskeletal biomarkers in health and disease: implications for the aging spine-a review for spinal surgeons by the SRS adult spinal deformity task force on senescence
- PMID: 40465097
- DOI: 10.1007/s43390-025-01124-w
Musculoskeletal biomarkers in health and disease: implications for the aging spine-a review for spinal surgeons by the SRS adult spinal deformity task force on senescence
Abstract
The incidence of spine-related pathologies is expected to increase in developed countries due to ongoing fundamental demographic shifts toward an older population. These changes present significant challenges to public health, as healthcare systems worldwide must confront the burden of musculoskeletal aging and its related consequences. Here, we synthesize current knowledge on the biologic mechanisms underlying musculoskeletal aging, focusing on the implications for the aging spine. The complexity of the aging process, characterized by a convoluted interplay between genetic, environmental, and lifestyle factors, necessitates a comprehensive understanding of the biologic processes and reliable methods of surveying biologic states to inform effective diagnostic, predictive, and prognostic strategies. Biomarkers emerge as invaluable tools in this domain, offering insights into the early detection, risk assessment, and targeted intervention for age-related musculoskeletal decline. This review highlights various biomarker types including diagnostic, predictive, and prognostic, and explores their distinct roles in enhancing our understanding of musculoskeletal aging. Navigating the interconnected landscape of cellular senescence, sarcopenia, osteoporosis, and frailty, this review underscores the critical importance of developing personalized care approaches for the aging population. By identifying and integrating functional biomarkers, researchers and clinicians can elucidate the underlying mechanisms and devise tailored strategies to alleviate the musculoskeletal decline associated with the aging process. We envision an "active surveillance" future where biomarkers of musculoskeletal aging are integrated into clinical practice, empowering clinicians to make proactive, data-driven decisions that improve spine health for older adults.
Keywords: Aging; Cellular senescence; Frailty; Musculoskeletal biomarkers; Spine surgery.
© 2025. The Author(s), under exclusive licence to Scoliosis Research Society.
Conflict of interest statement
Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose.
Similar articles
-
Mouse models of accelerated aging in musculoskeletal research for assessing frailty, sarcopenia, and osteoporosis - A review.Ageing Res Rev. 2024 Jan;93:102118. doi: 10.1016/j.arr.2023.102118. Epub 2023 Nov 5. Ageing Res Rev. 2024. PMID: 37935249 Review.
-
The Intersection of Sarcopenia and Musculoskeletal Pain: Addressing Interconnected Challenges in Aging Care.Int J Environ Res Public Health. 2025 Apr 2;22(4):547. doi: 10.3390/ijerph22040547. Int J Environ Res Public Health. 2025. PMID: 40283772 Free PMC article. Review.
-
Musculoskeletal health, frailty and functional decline.Best Pract Res Clin Rheumatol. 2014 Jun;28(3):395-410. doi: 10.1016/j.berh.2014.07.005. Epub 2014 Aug 16. Best Pract Res Clin Rheumatol. 2014. PMID: 25481423 Review.
-
Exploring cellular senescence in the musculoskeletal system: Any insights for biomarkers discovery?Ageing Res Rev. 2023 Jul;88:101943. doi: 10.1016/j.arr.2023.101943. Epub 2023 May 2. Ageing Res Rev. 2023. PMID: 37142059 Review.
-
The connection between aging, cellular senescence and gut microbiome alterations: A comprehensive review.Aging Cell. 2024 Oct;23(10):e14315. doi: 10.1111/acel.14315. Epub 2024 Aug 15. Aging Cell. 2024. PMID: 39148278 Free PMC article. Review.
References
-
- Moqri M, Herzog C, Poganik JR, Biomarkers of Aging Consortium, Justice J, Belsky DW, Higgins-Chen A, Moskalev A, Fuellen G, Cohen AA, Bautmans I, Widschwendter M, Ding J, Fleming A, Mannick J, Han J-DJ, Zhavoronkov A, Barzilai N, Kaeberlein M, Cummings S, Kennedy BK, Ferrucci L, Horvath S, Verdin E, Maier AB, Snyder MP, Sebastiano V, Gladyshev VN (2023) Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186:3758–3775 - PubMed - PMC - DOI
-
- Moqri M, Herzog C, Poganik JR, Ying K, Justice JN, Belsky DW, Higgins-Chen AT, Chen BH, Cohen AA, Fuellen G, Hägg S, Marioni RE, Widschwendter M, Fortney K, Fedichev PO, Zhavoronkov A, Barzilai N, Lasky-Su J, Kiel DP, Kennedy BK, Cummings S, Slagboom PE, Verdin E, Maier AB, Sebastiano V, Snyder MP, Gladyshev VN, Horvath S, Ferrucci L (2024) Validation of biomarkers of aging. Nat Med 30:360–372 - PubMed - PMC - DOI
-
- Tartiere AG, Freije JMP, López-Otín C (2024) The hallmarks of aging as a conceptual framework for health and longevity research. Front Aging. https://doi.org/10.3389/fragi.2024.1334261 - DOI - PubMed - PMC